期刊文献+

淋巴细胞趋化因子在慢性阻塞性肺疾病患者外周血中的表达及其对CD4^+CD8^+T细胞亚群的影响 被引量:4

Lymphocyte chemokine expression and its effect on peripheral blood CD4^+ CD8^+ T-cell subsets in patients with chronic obstructive pulmonary disease
原文传递
导出
摘要 目的 探讨淋巴细胞趋化因子(lymphotactin,XCL1)对COPD患者外周血CD4^+ T、CD8^+T细胞亚群及有关炎症因子的影响及机制。方法 随机选取13例COPD 患者(急性加重期和稳定期)和13名健康人,分离外周血T淋巴细胞进行培养,经淋巴细胞趋化因子干预后,用流式细胞仪分别检测外周血中CD4^+T、CD8^+ T 细胞亚群变化及其表面Fas、FasL 表达,并用酶联免疫吸附试验(enzymelinkedimmunosorbentassay,ELISA)分别检测血清及细胞培养上清液中的XCL1、IL-2表达水平。结果 AECOPD及稳定期患者外周血中的XCL1的表达均高于健康对照组(P 〈0.05),AECOPD组又高于稳定期组患者(P 〈0.05)。COPD患者(包括急性发作期与稳定期)T细胞培养液中,XCL1干预组与未干预组相比,XCL1、CD4^+-Fas、CD4^+-FasL、CD8^+-Fas、CD8^+-FasL 表达增高(P 〈0.05),CD4^+/CD8^+ 降低(P 〈0.05),而IL-2 表达减少(P 〈0.05)。且XCL1 的表达与CD4^+-Fas、CD4^+-FasL、CD8^+-Fas、CD8^+-FasL的表达呈正相关,与IL-2的表达及CD4^+/CD8^+ 呈负相关。结论 XCL1参与了COPD的炎症过程,其参与炎症反应的机制可能是通过促进Fas、FasL的表达,导致CD4^+T、CD8^+ T细胞的凋亡增加,CD4^+T/CD8^+T比值下降,造成CD4^+/CD8^+ 比例失衡,XCL1还可引起IL-2水平降低,间接导致机体免疫功能紊乱或低下,可能是导致COPD炎症持续存在的重要机制。 Objective In this study, we sought to investigate the relevance of lymphocyte chemokine (lymphotactin, XCL1) expression in patients with chronic obstructive pulmonary disease (COPD) and to analyze the effects of XCL1 expression on CD4^+ CD8^+ T-cell subsets and related inflammatory factors. Methods Thirteen patients with COPD [acute exacerbation (AE) and stable phase (SP) ] and 13 healthy individuals were included in the study. Peripheral blood T lymphocytes were isolated and cultured. After XCL1 intervention, subsets of peripheral blood CD4^+ CD8^+ T lymphocytes and expression of Fas and FasL were detected by flow cytometry. XCL1 and interleukin (IL)-2 expression in sera and cell culture supernatants were detected by enzyme-linked immunosorbent assay. Results XCL1 expression in the peripheral blood of patients with COPD (both AE and SP) was higher than that in healthy patients. Additionally,XCL1 expression was higher during AE than during SP. Analysis of T cells from the culture medium of COPD patients revealed that CD4^+ -Fas, CD4^+ FasL, CD8^+-Fas, and CD8^+- FasL subsets increased,while the CD4^+ CD8^+ subset decreased following XCL1 intervention. Moreover,IL-2 expression decreased, and XCL1 expression, as well as CD4^+ Fas, CD4 ^+ FasL, CD8^+ Fas, and CD8^+ -FasL subsets,were positively correlated with IL-2 expression, while the CD4^+ CD8^+ subset was negatively correlated. Conclusions XCL1 involved in the inflammatory process of COPD,which through by increasing the expression of Fas, FasL, and resulted in CD4^ + T, CD8 ^+ T cells apoptosis increased, CD4 ^+ T/CD8^+ T decreased, caused the imbalance of the proportion of CD4^+ /CD8^+. XCL1 also decreased the level of IL-2,thereby representing an important molecular player in the persistent inflammation observed in COPD.
出处 《国际呼吸杂志》 2015年第1期12-16,共5页 International Journal of Respiration
基金 深圳市龙岗区科技局课题(ys2012159)
关键词 慢性阻塞性肺疾病 淋巴细胞趋化因子 T淋巴细胞亚群 凋亡 白介素2 Chronic obstructive pulmonary disease Lymphocyte chemokine T lymphocyte subset Apoptosis Interleukin 2
  • 相关文献

参考文献14

  • 1Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population- based survey[J]. Am J Respir Crit Care Med, 2007,176 (8): 753-760.
  • 2Koch A, Gaczkowski M, Sturton G, et al. Modification of surface antigens in blood CD8+ T-lymphocytes in COPD: effects of smoking[J]. Eur Respir J, 2007,29 (1) : 42-50.
  • 3Crozat K, Guiton R, Contreras V, et al. The XC chemokine receptor 1 is a eoaserved selective marker of mammalian ceils homologous to mouse CDSalpha-I- dendritic cells[J]. J Exp Med, 2010,207(6) : 1283-1292.
  • 4Lei Y,Takahama Y. XCL1 and XCR1 in the immune system [J]. Microbes Infect,2012,14(3):262-267.
  • 5蔡柏蔷.慢性阻塞性肺疾病诊断、处理和预防全球策略(2011年修订版)解读[J].中华结核和呼吸杂志,2012,35(4):249-256. 被引量:156
  • 6Finkelstein R, Fraser RS, Ghezzo H, et al. Alveolar inflammation and its relation to emphysema in smokers[J]. Am J Respir Crit Care Med,1995,152(5 Pt 1) :1666-1672.
  • 7卓宋明,徐文莉,梁珊瑚,张春艳,叶春幸,余海彬,庄虹,许瑞环.慢性阻塞性肺疾病患者T淋巴细胞亚群凋亡与Fas、FasL、Bcl-2表达的关系[J].中华临床医师杂志(电子版),2011,5(6):1554-1560. 被引量:20
  • 8Cerdan C, Serfling E, Olive D. The C-class chemokine, lymphotactin,impairs the induction of Thl-type lymphokines in human CD4(-t-) T eells[J]. Blood,2000,96(2) :420-428.
  • 9Terpigorev SA, Novikov AA, E1-Zein BA, et al. Change in theblood cytokine spectrum in patients with pulmonary sarcoidosis[J]. Ter Arkh,2013,85(3) :23-27.
  • 10Kim MH, Lee SS, 1.ee SK, et al. lnterleukin-2 gene encoded stromal cells inhibit the growth of metastatic cholangiocarcinomas[ J ]. World J Gastroenterol, 2006, 12 (12),1889 1894.

二级参考文献22

  • 1慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华内科杂志,2007,46(3):254-261. 被引量:1796
  • 2杨月,李永春.慢性阻塞性肺疾病患者氧化剂损伤与抗氧化治疗的研究进展[J].实用心脑肺血管病杂志,2007,15(2):85-86. 被引量:3
  • 3Walke-Renard PB,Vaughan LM, Sahn SA. Chemical pleurodesis for malignant pleural effusions[J]. Ann Itern Med, 1994,120:56-64.
  • 4Ruckdeschel JC. Management of malignant pleural effusions: a overview[J]. Semin Oncol, 1988,15(3 suppl 3):24
  • 5石玛丽,王晓菲.过敏性哮喘患者激发试验后血中T淋巴细胞亚群变化的研究[J]中国实用内科杂志,1998(04).
  • 6DomagaΙa-Kulawik J,Hoser G,Dabrowska M,et al.Increased proportion of Fas positive CD8+cells in peripheral blood of patients with COPD. Respiratory Medicine . 2007
  • 7Jeffery PK.Lymphocytes, chronic bronchitis and chronic obstructive pulmonary disease. Novartis Foundation Symposium . 2001
  • 8Maulik N,Engelman R M,Rousou J A,et al.Ischemic preconditioning reduces apoptosis by upregulating anti-death gene Bcl-2. Circulation . 1999
  • 9Walum TA.The interleukin- 2 receptor miniserees. Journal of Biochemistry . 1991
  • 10Ebata T,Mogi S,Hata Y,et al.Rapid induction of CD95ligand and CD4+T cell-mediated apoptosis by CD137 (4-1BB)costimullation. European Journal of Immunology . 2001

共引文献175

同被引文献42

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部